Complement inhibition with an anti-c5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation

Transplantation

Volumn 60, Issue 11, 1995, Pages 1194-1202

  Kroshus, Timothy J ^a   Rollins, Scout A ^b   Dalmasso, Agustin P ^a   Elliott, Eileen A ^b   Matis, Louis A ^a   Squinto, Stephen P ^b   Morton Bolman, R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ALEXION PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5A; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; GRAFT REJECTION; HEART INJURY; HEART PERFUSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

ACUTE DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; COMPLEMENT ACTIVATION; COMPLEMENT C5; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, INBRED BALB C; MYOCARDIUM; PERFUSION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029593368     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199512150-00003     Document Type: Article

References (25)

1. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450.
2. Dalmasso AP, Vercellotti GM, Fischel RJ, Bolman RM, Bach FH, Platt JL. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
3. Dalmasso AP. The complement system in xenotransplantation. Immunopharmacology 1992; 24: 149.
4. Brauer RB, Baldwin WM III, Daha MR, Pruitt SK, Sanfilippo F. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 1993; 151: 7240.
5. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
6. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57: 363.
7. Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990; 249: 146.
8. Current protocols in immunology. New York: John Wiley & Sons, 1992.
9. Kent JF, Fife EH Jr. Precise standardization of reagents for complement fixation. Am J Trop Med 1963; 12: 103.
10. Laine RO, Esser AF. Identification of the discontinuous epitope in human complement protein C9 recognized by anti-melitin antibodies. J Immunol 1989; 143: 553.
11. Wurzner R, Schulze M, Happe L, et al. Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies. Complement Inflamm 1991; 8: 328.
12. Irwin ED, Bianco RW, Clack R, et al. Use of epicardial electrocardiograms for detecting cardiac allograft rejection. Ann Thorac Surg 1992; 54: 699.
13. Platt JL, Turman MA, Noreen HJ, Fischel RJ, Bolman RM, Bach FH. An ELISA assay for xenoreactive natural antibodies. Transplantation 1990; 49: 1000.
14. Falk RJ, Dalmasso AP, Kim V, et al. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest 1983; 72(2): 560.
15. Zhow XJ, Niesen N, Pawlowski I, et al. Prolongation of survival of discordant kidney xenografts by C6 deficiency. Transplantation 1990; 50: 896.
16. Pruitt SK, Baldwin WM, Marsh HC, Lin SS, Yeh CG, Bollinger RR. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 1991; 52: 868.
17. Xia W, Fearon DT, Moore FD Jr, Schoen FJ, Ortiz F, Kirkman RL. Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1. Transplant Proc 1992; 24: 479.
18. Vercellotti GM, Platt JL, Bach FH, Dalmasso AP. Neutrophil adhesion to xenogeneic endothelium via iC3b. J Immunol 1991; 146: 730.
19. Hattori R, Hamilton KK, McEver RP, Sims PJ. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 1989; 15: 9053.
20. Platt JL, Vercellotti GM, Lindman BJ, Oegema TR Jr, Bach FH, Dalmasso AP. Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med 1990; 171: 1363.
21. Platt JL, Dalmasso AP, Lindman BJ, Ihrcke NS, Bach FH. The role of C5a and antibody in the release of heparan sulfate from endothelial cells. Eur J Immunol 1991; 21: 2887.
22. Morgan BP. Cellular responses to the membrane attack complex. In Whaley K, Loos M, Weiler J, eds. Immunology and medicine 20. Kluwer Academic Publishers, 1993: 325.
23. Papadimitriou JC, Ramm LE, Drachenberg CB, Trump BF, Shin ML. Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9. J Immunol 1991; 147: 212.
24. Suttorp N, Seeger W, Zinsky S, Bhakdi S. Complement complex C5b-8 induced PGI2 formation in cultured endothelial cells. Am J Physiol 1987; 253: C13.
25. Kroshus TJ, Dalmasso AP, Leventhal JR, John R, Matas AJ, Bolman RM. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection. J Surg Res 1995; 59: 43.